Farmace, MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 119,288 |
| - |
| 25,464 |
| 24,191 |
| - |
| 45.46 |
| 20.28 |
| 24,238 |
| 2,393 |
| 0 |
| 26,631 |
| 2023 |
|---|
| 160,552 |
| - |
| 14,554 |
| 13,826 |
| - |
| 40.82 |
| 8.61 |
| 38,064 |
| 7,134 |
| 0 |
| 45,198 |
| 2024 |
|---|
| 147,312 |
| 147,312 |
| 9,060 |
| 8,607 |
| 8,607 |
| 12.50 |
| 5.84 |
| 46,670 |
| 42,446 |
| 694 |
| 88,422 |
Register and
explore Okredo data| 2024 |
|---|
| 147,312 |
| 147,312 |
| 9,060 |
| 8,607 |
| 8,607 |
| 12.50 |
| 5.84 |
| 46,670 |
| 42,446 |
| 694 |
| 88,422 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
147,312 €-8 % *
Sales per employee (€)
147,312 €- *
Profit before tax (€)
9,060 €-38 % *
Net Profit (€)
8,607 €-38 % *
Profit per employee (€)
8,607 €- *
Total profitability (%)
12.50 %-69.38 % *
Net profitability (%)
5.84 %-32.17 % *
Equity (€)
46,670 €23 % *
Amounts Payable And Liabilities (€)
42,446 €495 % *
Non-current Assets (€)
694 €- *
CurrentAssets (€)
88,422 €96 % *
